Seoul Pharma Co. Ltd Asset Resilience Ratio

Latest as of March 2025: 9.30%

Seoul Pharma Co. Ltd asset resilience ratio. Seoul Pharma Co. Ltd (018680) has an Asset Resilience Ratio of 9.30% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Seoul Pharma Co. Ltd (018680) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩6.64 Billion

≈ $4.50 Million USD Cash + Short-term Investments

Total Assets

₩71.39 Billion

≈ $48.38 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Seoul Pharma Co. Ltd (2012–2024)

Asset resilience ratio of Seoul Pharma Co. Ltd from 2012 to 2024. This chart shows how Seoul Pharma Co. Ltd's Asset Resilience Ratio has changed over time. Read 018680 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Seoul Pharma Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Seoul Pharma Co. Ltd (018680) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩5.66 Billion	7.93%
Short-term Investments	₩979.26 Million	1.37%
Total Liquid Assets	₩6.64 Billion	9.30%

Asset Resilience Insights

Limited Liquidity: Seoul Pharma Co. Ltd maintains only 9.30% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Seoul Pharma Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Seoul Pharma Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

Seoul Pharma Co. Ltd Asset Resilience Ratio by Year (2012–2024)

Seoul Pharma Co. Ltd asset resilience ratio by year from 2012 to 2024. The table below shows the annual Asset Resilience Ratio data for Seoul Pharma Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	10.53%	₩7.54 Billion ≈ $5.11 Million	₩71.62 Billion ≈ $48.54 Million	-4.74pp
2023-12-31	15.27%	₩9.66 Billion ≈ $6.55 Million	₩63.31 Billion ≈ $42.90 Million	-3.52pp
2022-12-31	18.79%	₩11.73 Billion ≈ $7.95 Million	₩62.43 Billion ≈ $42.31 Million	-3.41pp
2021-12-31	22.20%	₩13.82 Billion ≈ $9.37 Million	₩62.25 Billion ≈ $42.19 Million	-0.94pp
2020-12-31	23.14%	₩15.06 Billion ≈ $10.21 Million	₩65.09 Billion ≈ $44.11 Million	+12.33pp
2019-12-31	10.81%	₩7.67 Billion ≈ $5.19 Million	₩70.89 Billion ≈ $48.04 Million	+1.72pp
2018-12-31	9.09%	₩8.23 Billion ≈ $5.58 Million	₩90.57 Billion ≈ $61.38 Million	+4.00pp
2017-12-31	5.09%	₩4.43 Billion ≈ $3.00 Million	₩86.93 Billion ≈ $58.91 Million	-5.35pp
2016-12-31	10.45%	₩9.67 Billion ≈ $6.55 Million	₩92.54 Billion ≈ $62.71 Million	+10.19pp
2012-12-31	0.25%	₩153.00 Million ≈ $103.69K	₩60.68 Billion ≈ $41.12 Million	--

pp = percentage points

About Seoul Pharma Co. Ltd

KQ:018680 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$13.42 Million

₩19.81 Billion KRW

Market Cap Rank

#26152 Global

#1958 in Korea

Share Price

₩1699.00

Change (1 day)

-0.35%

52-Week Range

₩1687.00 - ₩3165.00

All Time High

₩17976.69